Is BLCO or RXST more undervalued in 2026?

CirclFi compares Bausch + Lomb Corporation (BLCO) and RxSight, Inc. (RXST) using 13 institutional-grade valuation models. BLCO has a Quality of Company score of 6.1/10 while RXST scores 6.8/10.

Which is a better buy — BLCO or RXST?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do BLCO and RXST valuations compare?

BLCO at $15.65 and RXST at $5.33 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

BLCO vs RXST Valuation Comparison 2026 — Intrinsic Value Analysis

BLCO

Ophthalmic Goods

Bausch + Lomb Corporation

Quality

6.1

out of 10

Value Trap

LOW

Price

$15.65

Last close

Models

10/13

Active

RXST

Ophthalmic Goods

RxSight, Inc.

Quality

6.8

out of 10

Value Trap

LOW

Price

$5.33

Last close

Models

11/13

Active

Model-by-Model Comparison

Model	Type	BLCO Fair Value	BLCO Upside	RXST Fair Value	RXST Upside
Bayesian DCF	Intrinsic	$4.03	-74.7%	$1.82	-65.9%
Earnings Power Value	Intrinsic	—	—	$6.07	-18.0%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$2.75	-82.6%	—	—
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for BLCO vs RXST — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

BLCO vs RXST — Which Stock Is More Undervalued?

RXST scores higher with a 6.8/10 quality rating vs BLCO's 6.1/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Bausch + Lomb Corporation (BLCO) and RxSight, Inc. (RXST) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

BLCO currently trades at $15.65 with a QOC of 6.1/10, while RXST trades at $5.33 with a QOC of 6.8/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).